ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1384	National Cancer Institute	Html	en	Breast Cancer Treatment and Pregnancy (PDQ®)–Health Professional Version	Breast cancer is the most common cancer in pregnant women and can be hard to detect because of changes in the breast that occur with pregnancy. Learn about the incidence, diagnosis, and treatment of breast cancer during pregnancy, as well as the effect a history of breast cancer can have on future pregnancies and children.	lactating women 0.489293 pregnant patients 0.451652 maternal risk factors. 0.471964 excisional biopsy 0.436656 unknown mapping methods 0.465613 bone scan delivers 0.472975 pregnant breast cancer 0.551836 endocrine therapy 0.452933 pregnancy study group 0.497501 pregnant women 0.605166 children 0.438022 breast examination 0.440643 mean gestational age 0.472372 gestational age 0.685559 bilateral ureteral reflux 0.456905 little risk 0.40821 congenital abnormalities 0.48754 fetal radiation exposure. 0.54026 patients 0.456683 natural tenderness 0.408433 trimester 0.554851 routine prenatal examination 0.479476 case reports 0.468475 age-matched population. 0.40591	breast preservation. 0.427847 palpable mass 0.407409 normal cardiac findings. 0.453276 fine-needle aspiration 0.408992 magnetic resonance imaging 0.471266 radiation delivered. 0.440906 harmful scatter radiation 0.506942 nonpregnant patients 0.413103 smaller retrospective series 0.451832 radiation exposure 0.619234 suspicious physical findings. 0.49123 prospective single-arm study 0.468244 multicenter case-control study 0.482053 limited prospective data 0.465326 Foley catheter drainage 0.474023 sentinel node biopsy 0.622944 breast cancer 0.95807 systematic review 0.463958 trastuzumab administration 0.445663 retrospective case series 0.470132 cancer treatment-exposed group 0.487835 methylene blue dye 0.469549 core biopsy 0.431953 postpartum radiation therapy 0.508953	CLICK HERE
1488	National Cancer Institute	Html	en	Metastatic Squamous Neck Cancer With Occult Primary Treatment (PDQ®)–Health Professional Version	Metastatic squamous neck cancer with occult primary occurs when squamous cell cancer spreads to lymph nodes in the neck from an undetectable primary tumor. Treatment includes surgery and radiation therapy. Learn about the diagnosis, survival, staging, and treatment of these tumors.	primary site. 0.436234 moderately differentiated tumors 0.539497 Thyroid function testing 0.46762 massive homolateral adenopathy 0.465434 EBV genomic material 0.535385 metastatic carcinoma 0.482369 lymph node dissection 0.549764 probable primary site 0.571551 germ cell tumor 0.575226 PDQ cancer information 0.618029 cervical lymph nodes. 0.554105 poorly differentiated tumors 0.545473 entire thyroid gland 0.457464 cancer information summary 0.595141 Primary tumors 0.485135 palpable tumor 0.472764 breast cancer prevention 0.4696 adequate neck dissection 0.527836 primary physician 0.522652 patients 0.45154 poorly differentiated tumor 0.752934 fine-needle aspiration biopsy 0.484684 epstein-barr virus 0.506145 NCI PDQ cancer 0.504517 lower neck 0.447545	radiation therapy 0.728398 cervical nodal tissue 0.52026 squamous carcinoma 0.531992 magnetic resonance imaging 0.467707 neck mass 0.432409 DNA amplification 0.492378 metastatic squamous cell 0.564542 neck primary site 0.62075 germ cell malignancies 0.487658 metastatic lymph node 0.63625 overt nasopharyngeal carcinoma. 0.485019 cervical lymph node 0.754988 obvious metastatic disease 0.554252 polymerase chain reaction 0.487648 cervical node metastases 0.558588 Squamous carcinomas 0.45824 external-beam radiation therapy 0.502847 Periodic Acid Schiff 0.471213 unknown primary 0.44413 platinum-based combination chemotherapy 0.478329 undifferentiated carcinoma 0.456062 neck tumors 0.464529 occult primary tumor 0.948651 lymph node metastases 0.623031	CLICK HERE
1626	National Cancer Institute	Html	en	Liver (Hepatocellular) Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.	HCV infections 0.396129 Long-term iron depletion 0.434578 CHC patients 0.518812 HCC incidence 0.527647 considerable progress 0.374353 viral infections 0.460226 ethnic groups 0.382981 similar symptoms 0.373956 Hepatitis B virus 0.560635 greater risk 0.376989 iron depletion 0.497763 severe liver fibrosis 0.434898 HCC 0.672571 hepatitis C. 0.612223 Age-standardized incidence rates 0.469423 cancer mortality worldwide 0.478797 iron depletion therapy 0.43959 mild iron deficiency 0.431003 monthly maintenance phlebotomy 0.440922 hepatitis B infection 0.565315 global public health 0.444379 chronic disease 0.39654 long-term liver problems 0.441516 main causes 0.378422 new cases 0.385753	hepatocellular cancer 0.460335 HCV-related chronic hepatitis 0.651512 white men. 0.38629 United States 0.759498 long duration 0.376762 natural history 0.377715 geographic region. 0.381817 common cancer 0.445599 North America. 0.386623 hepatitis C virus 0.560378 underwent weekly phlebotomy 0.443537 cancer mortality worldwide. 0.479228 viral hepatitis 0.542971 higher risk 0.375814 biopsy-proven CHC patients 0.468182 distinct male preponderance 0.461131 CHC account 0.409155 chronic hepatitis 0.921284 frequent viral infections 0.45994 previous interferon 0.372717 liver cancer 0.397286 acute infections 0.383971 serum alanine aminotransferase 0.429339 Asians/Pacific Islanders 0.385493	CLICK HERE
1699	National Cancer Institute	Html	en	Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gestational trophoblastic disease.	cancer treatment 0.629773 distant parts 0.609964 gestational trophoblastic tumor 0.634863 ongoing clinical trials 0.615611 gestational trophoblastic disease 0.980639 body 0.6821 PDQ cancer information 0.678639 clinical trial search 0.680326 uterus 0.71162 clinical trials 0.968129 High blood pressure 0.608092 placental-site trophoblastic tumor 0.671479 cancer information summary 0.644738 invasive mole 0.617754 clinical trial 0.770607 invasive moles 0.613464 patients 0.609009 hydatidiform mole 0.658477 blood vessels 0.619408 treatment clinical trial 0.593684 trophoblastic tumor 0.676329 NCI PDQ cancer 0.598837 molar pregnancy 0.617282 gestational trophoblastic neoplasia 0.841921 radiation therapy 0.657265	Treatment Editorial Board 0.593622 General information 0.600341 treatment 0.803629 hydatidiform moles 0.589637 NCI-supported cancer 0.614308 cancer cells 0.665812 Cancer Information Service 0.589805 tumor forms 0.590743 normal pregnancy 0.631307 treatment clinical trials 0.63304 National Cancer Institute 0.644064 new treatment 0.629182 epithelioid trophoblastic tumors 0.658247 epithelioid trophoblastic tumor 0.673512 Trophoblastic Disease Treatment 0.618342 combination chemotherapy 0.60364 blood 0.654851 gestational trophoblastic tumors 0.669932 cancer clinical trials 0.694698 human chorionic gonadotropin 0.796334 tumor 0.770797 cancer 0.954041 appropriate cancer treatment 0.604611 standard treatment 0.593708	CLICK HERE
1750	National Cancer Institute	Html	null	BRCA1 and BRCA2: Cancer Risk and Genetic Testing	A fact sheet about the BRCA1 and BRCA2 genes, what to do if a person tests positive for alterations in one of these genes, and consequences of genetic testing.			CLICK HERE
1847	National Cancer Institute	Html	es	Tratamiento del cáncer de vejiga (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vejiga.	Ta T1 bladder 0.362863 BCG vs 0.318538 prognostic factors 0.316381 urinary tract tumors 0.311024 quimioterapia intravesical posoperatoria 0.468241 Sin embargo 0.334145 G1Ta bladder 0.318831 risk groups 0.312464 stage t1 tumors 0.314985 bladder cancer 0.962527 Bladder Cancer Meta-analysis 0.326886 Tumor progression 0.313249 Millán-Rodríguez F 0.322816 pelvis renal 0.364298 Malignant bladder tumors 0.321161 non-muscle-invasive urothelial carcinoma 0.385032 stage ta t1 0.32667 bladder tumors 0.386807 Estados Unidos 0.326159 Natl Cancer Inst 0.319662 Manoharan M 0.311152 patients with 0.393406 Chéchile-Toniolo G 0.322599 Babjuk M 0.331941 vejiga ta 0.335749	Sylvester R 0.333215 Ta urothelial carcinoma 0.313829 Eur Urol 0.378134 vejiga carcinomas 0.326934 urinary tract 0.330369 with stage ta 0.327583 bladder followed 0.317421 BCG intravesical demora 0.315841 Cancer Staging Manual 0.319905 Soloway MS 0.311003 cell carcinoma 0.326726 patients with stage 0.336429 Salvador-Bayarri J 0.322164 Sylvester RJ 0.317663 urinary bladder 0.354046 Clin Oncol 0.331355 Oosterlinck W 0.385864 EAU guidelines 0.334682 urothelial carcinoma 0.440061 bladder toxicity from 0.319949 vejiga estadio 0.322563 Radical cystectomy 0.328383 AJCC Cancer Staging 0.320707 metastatic urothelial carcinoma 0.311479	CLICK HERE
1961	National Cancer Institute	Html	es	Tratamiento del cáncer de vulva (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vulva.	estadios iva 0.421275 rayo angosto 0.420414 Vulvar Cancer 0.417101 siguientes procedimientos 0.541792 IB.Ampliar Tamaños 0.422647 estadio iv 0.58857 tinte circula 0.426876 rayo x 0.423229 vulva recidivante 0.648879 siguientes aspectos 0.430874 estadio ii 0.610359 ganglios linfáticos.ampliar milímetros 0.472722 estadios ia 0.421501 ganglio linfático centinela 0.970223 vía oral 0.418459 rayos x 0.422238 estadio ivb 0.479845 estadio ib 0.448972	estadio ia 0.448137 enlace drugs approved 0.431501 Vulvectomía tegumentaria 0.424681 National Cancer Institute 0.419214 estadios iiia 0.423069 Instituto Nacional 0.434203 estadio iiia 0.448591 PDQ Tratamiento 0.437982 estadio iiic 0.447516 estadio iva cáncer 0.523085 Physician Data Query 0.469403 prueba pap 0.425219 lápiz mide 0.424089 estadio iii 0.594503 vulva evoluciona 0.623314 vulva causa efectos 0.543623 siguientes pruebas 0.431957 siguientes estadios 0.427405	CLICK HERE
2006	National Cancer Institute	Html	es	Tratamiento del feocromocitoma y paraganglioma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del feocromocitoma y el paraganglioma.	glándula tiroides 0.609278 glándulas suprarrenales ayuda 0.631749 siguientes procedimientos 0.696393 siguientes aspectos 0.575361 Neurofibromatosis tipo 0.579395 siguientes síndromes 0.595261 vía oral 0.53652 rayos x 0.649118 tumores neuroendocrinos 0.602024 National Cancer Institute 0.520886 paraganglioma causa efectos 0.753898 siguientes riesgos 0.518888 endocrina múltiple tipo 0.630502 feocromocitoma hereditario 0.929917	Instituto Nacional 0.540854 PDQ Tratamiento 0.549585 insuficiencia suprarrenal aguda 0.595836 Mucha sudación 0.56538 partes distantes 0.527507 Physician Data Query 0.586955 siguientes situaciones 0.586373 siguientes características 0.581278 von hippel-lindau 0.636326 TEP -FDG 0.553345 enfermedad.ampliar paraganglioma 0.655429 Períodos súbitos 0.521079 siguientes medicamentos 0.565161 siguientes pruebas 0.590766	CLICK HERE
2958	National Cancer Institute	Html	en	Making a Quit Plan	Planning ahead improves your chances of quitting smoking for good. Follow these steps to create your own individual quit plan.	health care provider 0.682085 common smoking reminders 0.549 ashtrays 0.452031 easy steps 0.487737 NRT 0.496038 healthy snacks 0.472018 energy level 0.475958 special treat 0.473544 word QUIT 0.556414 nicotine replacement therapy 0.840728 items—like straws 0.475777 quit plan 0.979663 favorite songs 0.473638 triggers 0.466512 list 0.464107 text message 0.469947 friends 0.440731 online chat 0.467529 chances 0.434282 young adults 0.470223 cigarettes 0.452193 monitor progress 0.465509 big accomplishment 0.488463 United States 0.472032 smoke breaks 0.469072	regular exercise 0.473275 National Cancer Institute 0.530065 NCI LiveHelp page 0.544024 text messaging service 0.527129 craving 0.4367 good mood 0.477991 cravings 0.511271 Smokefree Apps help 0.573957 movie night 0.475119 Nicotine withdrawal 0.548423 Practice deep breathing 0.541377 cigarette money 0.475711 huge achievement 0.482604 Eastern Time 0.480147 nicotine gum 0.500974 different pleasure 0.478743 cigarette butts 0.473635 withdrawal symptoms 0.585184 activities 0.427718 smokefree milestone 0.520259 time 0.49243 online calendars 0.483411 smoking cessation counselor 0.535799 family 0.428198	CLICK HERE
17220	National Cancer Institute	Html	es	TMIST (Estudio de detección de cáncer con imágenes mamográficas de tomosíntesis)	TMIST es un estudio aleatorizado de exámenes de detección de cáncer de seno que compara dos tipos de mamografía digital aprobados por la FDA, la mamografía digital (2-D) convencional con una tecnología más nueva llamada mamografía de tomosíntesis (3-D).	banco de tejido para investigaciones 0.91708 2D toma imágenes 0.651864 seno o cambios 0.988947 imagen plana. Las imágenes 0.847588 Tienen antecedentes familiares 0.628035	Cáncer ECOG-ACRIN 0.605173 estudio tmist 0.926327 pruebas genéticas o cambios 0.786757 Estados Unidos 0.661646	CLICK HERE